MET:CMEMicro Ether Futures Analysis

MetLife (MET) is trading at $85.58, comfortably above its 20‑day SMA of 84.60, 50‑day SMA of 80.81 and 200‑day SMA of 78.18, confirming a bullish trend despite a marginally bearish MACD histogram. The RSI sits at 57.7, indicating modest momentum without overbought pressure, while volume is on an increasing trajectory and 30‑day volatility is elevated at 21.4%, suggesting active price swings. Support is anchored near $80.51 and resistance near $89.62, framing a price corridor that aligns with the current market price, and the extreme greed reading of 91.46 on the Fear & Greed Index reflects strong investor appetite. The forward P/E of 7.78 versus a trailing P/E of 16.55 points to anticipated earnings acceleration, complemented by a dividend yield of 2.77% that enhances total return potential. A computed beta of -0.18 suggests low sensitivity to market swings, while the modest max drawdown of -18.3% underscores resilience. Taken together, these fundamentals support a cautiously optimistic stance, favoring a hold‑to‑buy bias across horizons.